CTBO (Cantabio Pharmaceuticals) Total Equity: $-1.89 Mil (As of Dec. 2018)


What is Cantabio Pharmaceuticals Total Equity?

Cantabio Pharmaceuticals CTBO Total Equity is $-1.89 Mil as of Dec. 2018.

Cantabio Pharmaceuticals's total equity for the quarter that ended in Dec. 2018 was $-1.89 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Cantabio Pharmaceuticals Total Equity Historical Data

* Premium members only.

The historical data trend for Cantabio Pharmaceuticals's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cantabio Pharmaceuticals Total Equity Chart

Cantabio Pharmaceuticals Annual Data
Trend Mar12 Mar13 Mar14 Mar15 Mar16 Mar17 Mar18
Total Equity
Get a 7-Day Free Trial -0.00 -0.22 -0.37 -0.85 -1.87

Cantabio Pharmaceuticals Quarterly Data
Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.80 -1.87 -2.30 -2.42 -1.89

Cantabio Pharmaceuticals Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Cantabio Pharmaceuticals's Total Equity for the fiscal year that ended in Mar. 2018 is calculated as

Total Equity=Total Assets(Q: Mar. 2018 )-Total Liabilities(Q: Mar. 2018 )
=0.109-1.983
=-1.87

Cantabio Pharmaceuticals's Total Equity for the quarter that ended in Dec. 2018 is calculated as

Total Equity=Total Assets(Q: Dec. 2018 )-Total Liabilities(Q: Dec. 2018 )
=0.326-2.215
=-1.89

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of $-1.89 Mil mean?
Cantabio Pharmaceuticals (CTBO) has a Total Equity of $-1.89 Mil as of Dec. 2018. The total amount of equity as record on a company's balance sheet. View historical data for Cantabio Pharmaceuticals and its competitors.
Is Cantabio Pharmaceuticals' Total Equity too high?
Cantabio Pharmaceuticals' current Total Equity is $-1.89 Mil.
How does Cantabio Pharmaceuticals' Total Equity compare to TNTY and ETNI?
Cantabio Pharmaceuticals' Total Equity of $-1.89 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Biotechnology company?
A good Total Equity depends on the Biotechnology industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Cantabio Pharmaceuticals and its competitors. Cantabio Pharmaceuticals's current Total Equity is $-1.89 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cantabio Pharmaceuticals stock overvalued right now?
Cantabio Pharmaceuticals (CTBO) has a current Total Equity of $-1.89 Mil. The current Total Equity is $-1.89 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Cantabio Pharmaceuticals (CTBO), the current Total Equity is $-1.89 Mil as of Dec. 2018. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cantabio Pharmaceuticals Business Description

Address 1250 Oakmead Parkway, Sunnyvale, CA, USA, 94085
Cantabio Pharmaceuticals Inc is the United States based preclinical stage biotechnology company. It is focused on commercializing novel therapies and the intellectual property generated from its research and development activities for Parkinson's disease and Alzheimer's disease and other related diseases. In addition, In addition, it is also engaged in the development of therapeutic proteins that can pass through the blood-brain barrier and supplement in vivo levels of proteins which display loss of function during disease conditions.